First Tracks Biotherapeutics TRAX
NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

First Tracks Biotherapeutics (TRAX) Long-Term Investments (2024)

Updated

Analysis

First Tracks Biotherapeutics (TRAX) Long-Term Investments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 387.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 63.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 268.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.45 Bn
10 First Tracks Biotherapeutics 1.66 Bn 740.14 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 35.47 Mn
API Access

First Tracks Biotherapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=TRAX&period=max&api_key=YOUR_API_KEY